Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Pr3vent
AI-based newborn eye disease screener closes $1.5M Series A round
By
Dave Muoio
|
01:03 pm |
February 14, 2019
Pr3vent's non-invasive tool looks to catch ophthalmic conditions when kids are still young.